Angiogenesis inhibitor 7
Angiogenesis inhibitor 7 (compound BT2) ia a potent inhibitor of angiogenesis. Angiogenesis inhibitor 7 inhibits ERK phosphorylation, FosB/ΔFosB and VCAM-1 expression[1].
Product Specifications
CAS Number
922029-50-3
UNSPSC
12352005
Target
AP-1; ERK
Related Pathways
Immunology/Inflammation; MAPK/ERK Pathway; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Smiles
O=C(NC1=CC=C2OC3=C(N(CC)C(C2=C1)=O)C=CC=C3)OCC
Molecular Formula
C18H18N2O4
Molecular Weight
326.35
References & Citations
[1]NewSouth Innovations Pty Limited. Treatment methods comprising administering inhibitors of FosB/ΔFosB expression and/or VCAM-1 expression and/or ERK1/2 phosphorylation. World Intellectual Property Organization, WO2021184059 A1 2021-09-23
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
FosB
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Cr5607-1mgEcoli 1 mg (E. coli)
Recombinant Staphylococcus Aureus ald2 Protein (aa 1-372) (strain N315)
Sign In for Pricing
View Details 
TA506227S 30 µL
PDGF Receptor beta (PDGFRB) Mouse Monoclonal Antibody [Clone ID: OTI1G9]
Sign In for Pricing
View Details